[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) Form 144 notice reports a proposed sale of 19,410 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,000,006.40, scheduled approximately for 09/02/2025 on NASDAQ. The shares were acquired as Founders Shares from the issuer on 12/27/2023. The filing also discloses 10b5-1 plan sales in the prior three months: 281,250 shares by WEST CLAY CAPITAL LLC for $24,777,421.88 and two trust sales of 21,531 shares each for $1,896,827.27 each, all dated 08/20/2025. Total shares outstanding reported in the form are 370,470,348. The filer certifies no undisclosed material adverse information and references reliance on Rule 10b5-1 where applicable.

Positive

• Full disclosure of planned sale including broker, share count, market value, and approximate sale date
• Prior 10b5-1 sales disclosed with gross proceeds, improving transparency about recent insider dispositions
• Acquisition details provided (Founders Shares, acquisition date 12/27/2023), which clarifies provenance of securities

Negative

• Filing extract lacks visible signature details and explicit plan adoption date in the provided text, which could be a procedural gap if missing from actual submission
• Large prior 10b5-1 sale (281,250 shares for $24.78M) may attract investor scrutiny despite current sale being small

Insights

Securities Analyst

TL;DR: Routine insider sale notice; disclosed prior 10b5-1 transactions are large in absolute terms but consistent with planned dispositions.

The filing documents a small proposed disposition relative to the issuer's outstanding shares: 19,410 shares versus 370,470,348 shares outstanding, representing a de minimis fraction of equity. Prior 10b5-1 sales on 08/20/2025 were sizable in absolute dollars, particularly the 281,250-share sale generating $24.78 million, indicating material liquidity events by related parties earlier this quarter. For investors, the current notice reads as a routine founder-originated sale rather than an operational signal, but the magnitude of recent plan sales may warrant attention if coupled with other disclosures.

Corporate Governance / Compliance Expert

TL;DR: Form 144 appears complete for a Rule 144/10b5-1 disclosure; statements include the required representations.

The form lists acquisition details, broker information, planned sale date, and recent 10b5-1 sales, and includes the signature representation regarding material non-public information. The presence of explicit plan-sale dates and gross proceeds supports compliance transparency. No regulatory issues or gaps are apparent from the supplied text, though the filing omits signature block specifics and plan adoption date fields in the extract provided. If those items are absent in the actual filing, that would be a procedural omission requiring correction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19410	2000006.40	370470348	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2023	Founders Shares	Issuer			19410	12/27/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	281250	24777421.88
10b5-1 Sales for YOLO APV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	21531	1896827.27
10b5-1 Sales for YOLO ECV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	21531	1896827.27

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the CRWV Form 144 propose to sell?

The notice proposes sale of 19,410 common shares on or about 09/02/2025 via Morgan Stanley Smith Barney LLC.

What is the aggregate market value of the proposed CRWV sale?

The aggregate market value reported is $2,000,006.40.

When and how were the shares being sold acquired?

The 19,410 shares were acquired as Founders Shares from the issuer on 12/27/2023.

What insider sales did the filing disclose from the past three months for CRWV?

The filing lists 10b5-1 sales on 08/20/2025: WEST CLAY CAPITAL LLC sold 281,250 shares for $24,777,421.88, and two trusts each sold 21,531 shares for $1,896,827.27.

How many CRWV shares are outstanding according to the filing?

The form reports 370,470,348 shares outstanding.